V-01
Sign in to saveV-01 is a protein subunit COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group Inc. __TOC__ == Preclinical studies ==
~1 min read
Encyclopedic overview
3 sectionsContents
- Preclinical studies
- Clinical studies
- References
V-01 is a protein subunit COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group Inc. __TOC__ == Preclinical studies ==
A preclinical study in rhesus macaques was published in July 2021. The vaccine's ability to neutralize several variants of concern has also been tested in mice. Another study in mice tested V-01 as a booster after inactivated Covid vaccine, including neutralization of a range of variants of concern.
Excerpted from Wikipedia’s “V-01” article, available under the CC BY-SA 4.0 licence.